Company Filing History:
Years Active: 2018
Title: The Innovations of Markus Eser
Introduction
Markus Eser is a notable inventor based in Düsseldorf, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of CD3 binding domains. His work has implications for therapeutic applications, showcasing the potential of his inventions in medical science.
Latest Patents
Markus Eser holds 1 patent related to his invention of humanized CD3 binding sites. This invention includes a variable heavy chain domain (VH) and a variable light chain domain (VL) with specific sequences that enhance stability while maintaining binding affinity. The mutations at positions VH111 and VL49 are crucial for the improved performance of these binding sites.
Career Highlights
Throughout his career, Markus Eser has worked with various companies, including Affirmed GmbH and Affimed GmbH. His experience in these organizations has allowed him to refine his skills and contribute to innovative projects in the biotechnology sector.
Collaborations
Markus has collaborated with notable professionals in his field, including Eugene Zhukovsky and Melvyn Little. These partnerships have further enriched his work and expanded the impact of his inventions.
Conclusion
Markus Eser's contributions to the field of biotechnology, particularly through his patent on CD3 binding domains, highlight his innovative spirit and dedication to advancing medical science. His work continues to inspire future developments in therapeutic applications.